ArticleBone marrow transplantation2026

The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

Anna Ossami Saidy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.